These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15003082)

  • 1. Academic highlights: emerging therapeutic strategies in Alzheimer's disease.
    Grossberg GT; Corey-Bloom J; Small GW; Tariot PN
    J Clin Psychiatry; 2004 Feb; 65(2):255-66; quiz 283-4. PubMed ID: 15003082
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs for cognitive loss and dementia.
    Treat Guidel Med Lett; 2013 Oct; 11(134):95-100; quiz 1 p following p100.. PubMed ID: 24081314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 4. Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer's dementia.
    Owen RT
    Drugs Today (Barc); 2016 Apr; 52(4):239-48. PubMed ID: 27252988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Alzheimer drugs: life-threatening adverse effects.
    Prescrire Int; 2007 Feb; 16(87):16. PubMed ID: 17326275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical treatment of Alzheimer's disease].
    Johannsen P
    Ugeskr Laeger; 2006 Oct; 168(40):3424-9. PubMed ID: 17032609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Practical clinical use of therapeutic agents for Alzheimer's disease].
    Arai T
    Nihon Yakurigaku Zasshi; 2007 Dec; 130(6):494-8. PubMed ID: 18079601
    [No Abstract]   [Full Text] [Related]  

  • 10. Memantine: new preparation. Poor evaluation and uncertain benefit in Alzheimer's disease.
    Prescrire Int; 2003 Dec; 12(68):203-5. PubMed ID: 14986682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease.
    Farlow MR
    Geriatrics; 2004 Jun; 59(6):22-7. PubMed ID: 15224791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antidementia drugs and risk of pneumonia in older persons with Alzheimer's disease.
    Lampela P; Tolppanen AM; Tanskanen A; Tiihonen J; Lavikainen P; Hartikainen S; Taipale H
    Ann Med; 2017 May; 49(3):230-239. PubMed ID: 27786552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's: new developments, new hope.
    Consum Rep; 2004 Oct; 69(10):48. PubMed ID: 15366212
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alzheimer type dementia].
    Ruis J
    Rev Infirm; 2008 Sep; (143):14-5. PubMed ID: 18788658
    [No Abstract]   [Full Text] [Related]  

  • 15. Alzheimer's disease: beware of interactions with cholinesterase inhibitors.
    Prescrire Int; 2006 Jun; 15(83):103-6. PubMed ID: 16764099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Reversible" Alzheimer's disease?
    Peter F; Susanne J; Margareta H; Silvia W; Wolfgang K; Thomas L; Heinz TK
    J Am Geriatr Soc; 2011 Jun; 59(6):1137-8. PubMed ID: 21668917
    [No Abstract]   [Full Text] [Related]  

  • 17. Agitation in Alzheimer's disease: no to donepezil. Psycho-behavioural measures are better option.
    Prescrire Int; 2008 Oct; 17(97):212. PubMed ID: 19536942
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacologic treatment options in Alzheimer's disease: optimizing disease management.
    Aisen PS
    J Am Acad Nurse Pract; 2005 Mar; Suppl():5-7. PubMed ID: 16033023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 20. Effective pharmacological management of Alzheimer's disease.
    Atri A
    Am J Manag Care; 2011 Nov; 17 Suppl 13():S346-55. PubMed ID: 22214392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.